TNFRSF11B and osteoporosis: OPG prevents osteoclast formation by blocking RANKL binding site and preventing RANKL from forming complex with RANK receptor, thus inhibiting bone resorption and thereby avoiding the occurrence of osteoporosis (Kurinami et al., 2016; Maria et al., 2018).